Table 2

Effects of DS-8500a on glycemic and lipid parameters

Placebo (n=33)10 mg DS-8500a (n=32)75 mg DS-8500a (n=34)
BaselineDay 28Change from baseline to day 28BaselineDay 28Change from baseline to day 28LSM difference versus placeboBaselineDay 28Change from baseline to day 28LSM difference versus placebo
24-hour WMG (mmol/L)11.08±1.9311.34±2.120.23 (−0.16 to –0.62)11.59±2.0211.03±2.15−0.51 (−0.90 to −0.12)*−0.74 (−1.29 to –0.19)††11.26±2.4710.42±2.08−0.82 (−1.20 to −0.43)***−1.05 (−1.59 to –0.50)†††
FPG (mmol/L)8.59±1.548.49±1.78−0.14 (−0.48 to 0.20)9.17±1.658.73±1.60−0.34 (−0.69 to 0.01)−0.20 (−0.69 to 0.29)8.60±1.927.69±1.41−0.93 (−1.27 to −0.59)***−0.79 (−1.27 to –0.31)††
2-hour PPG after breakfast (mmol/L)14.07±2.5514.20±2.800.03 (−0.63 to 0.69)14.85±2.5513.92±3.01−0.83 (−1.50 to –0.16)*−0.86 (−1.80 to 0.08)14.51±3.1113.04±2.47−1.42 (−2.08 to −0.76)***−1.45 (−2.38 to –0.52)††
2-hour PPG after lunch (mmol/L)12.73±2.6513.27±2.870.50 (−0.14 to 1.13)13.72±2.7413.07±3.23−0.56 (−1.21 to 0.08)−1.06 (−1.97 to –0.15)†12.87±3.0612.03±2.96−0.82 (−1.45 to −0.19)*−1.32 (−2.21 to –0.42)††
2-hour PPG after dinner (mmol/L)14.23±2.2814.99±2.480.68 (0.10 to 1.26)*15.05±2.6314.59±2.89−0.36 (−0.95 to 0.23)−1.04 (−1.87 to –0.21)†14.46±2.5814.01±2.31−0.53 (−1.10 to 0.05)−1.21 (−2.03 to –0.39)††
Fasting plasma insulin (pmol/L)46.6±27.545.9±24.8−0.41 (−4.85 to 4.03)41.5±17.739.7±19.6−2.17 (−6.68 to 2.34)−1.76 (−8.10 to 4.58)44.5±26.543.1±29.3−1.41 (−5.85 to 3.02)−1.00 (−7.28 to 5.27)
 Fasting plasma C-peptide (nmol/L)0.594±0.2290.608±0.2240.014 (−0.018 to 0.045)0.557±0.1440.558±0.1550.002 (−0.030 to 0.034)−0.011 (−0.056 to 0.034)0.595±0.2160.583±0.284−0.012 (−0.043 to 0.019)−0.026 (−0.070 to 0.019)
Insulin AUC0–4h (pmol/L·h)737.4±448.4729.1±421.0−3.52 (−52.05 to 45.01)629.9±311.8607.5±278.1−33.25 (−82.74 to 16.25)−29.73 (−99.21 to 39.76)735.1±462.3775.3±424.436.67 (−11.88 to 85.22)40.19 (−28.37 to 108.8)
C-peptide AUC0–4h (nmol/L·h)6.05±2.096.19±2.000.147 (−0.105 to 0.399)5.63±1.545.73±1.560.080 (−0.178 to 0.337)−0.067 (−0.428 to 0.294)6.15±2.116.75±2.260.569 (0.316, 0.821)**0.422 (0.065 to 0.778)†
Glucose AUC0–4h (nmol/L·h)50.52±7.9950.98±9.070.21 (−1.73 to 2.14)53.32±8.8050.37±9.62−2.59 (−4.57 to –0.62)*−2.80 (−5.58 to –0.03)†51.37±10.5346.92±8.59−4.42 (−6.35 to −2.49)**−4.63 (−7.36 to –1.89)†
Insulin AUC0–4h/glucose AUC0–4h15.32±10.7615.26±10.690.002 (−0.005 to 0.009)12.26±6.7312.67±6.380.010 (0.003 to 0.017)*0.008 (−0.002 to 0.017)14.98±9.3917.29±10.210.023 (0.017 to 0.030)**0.021 (0.012 to 0.031)††
C-peptide AUC0–4h/glucose AUC0–4h0.124±0.0510.127±0.053−0.003 (−1.190 to 1.162)0.109±0.0380.119±0.0420.307 (−0.894 to 1.508)0.321 (−1.368 to 2.009)0.124±0.0460.149±0.0562.121 (0.946 to 3.296)**2.135 (0.476 to 3.794)†
TC (mmol/L)4.96±0.684.86±0.70−0.111 (−0.253 to 0.029)5.06±0.804.91±0.82−0.154 (−0.298 to –0.012)*−0.043 (−0.244 to 0.158)5.15±0.844.63±0.82−0.528 (−0.669 to −0.387)**−0.417 (−0.617 to –0.216)††
HDL-C (mmol/L)1.15±0.291.12±0.30−0.025 (−0.055 to 0.059)1.13±0.271.15±0.250.015 (−0.016 to 0.046)0.039 (−0.004 to 0.083)1.10±0.261.25±0.280.141 (0.110 to 0.171)**0.166 (0.122 to 0.209)††
LDL-C (mmol/L)3.28±0.643.12±0.68−0.161(−0.299 to –0.024)*3.25±0.733.21±0.76−0.044 (−0.184 to 0.096)0.117 (−0.079 to 0.313)3.35±0.652.96±0.75−0.387 (−0.525 to −0.249)**−0.225 (−0.420 to –0.031)†
Triglycerides (mmol/L)1.72±1.031.89±1.270.117 (−0.094 to 0.329)1.97±1.091.71±0.92−0.237 (−0.451 to −0.022)−0.354 (−0.656 to –0.052)†1.96±1.211.33±0.68−0.615 (−0.826 to −0.403)**−0.732 (−1.032 to –0.432)††
  • Results are presented as the mean±SD, LSM (95% CI) versus baseline, or LSM (95% CI) versus placebo.

  • *p< 0.05, **p<0.01, ***p<0.001 versus baseline; †p<0.05, ††p<0.01, †††p<0.001 versus placebo.

  • AUC0–4h, area under the concentration–time curve from 0 to 4 hours; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LSM, least squares mean; PPG, postprandial plasma glucose; TC, total cholesterol; WMG, weighted mean glucose.